Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Orexigen Therapeutics received early financing of $11.0M on 2004-01-22.
| Series | Round size | Date |
|---|---|---|
| Series A | $11M | 01/2004 |
| Series B | $35M | 04/2005 |
| Series C | $30M | 11/2006 |
| Post Ipo Equity | $60M | 09/2015 |
| Post Ipo Equity | $165M | 03/2016 |
| Investors | Security type |
|---|---|
| SOFINNOVA INVESTMENTS INC | Series A |
| Kleiner Perkins | Series A |
| Domain Associates | Series A |
| Scale Venture Partners | Series B |
| Morgenthaler Ventures | Series B |
| Kleiner Perkins | Series B |
| Greenspring Associates | Series B |
| Domain Associates | Series B |
| Duke University | Series B |
| Montreux Equity Partners | Series B |
| MPM Capital | Series C |
| WASATCH ADVISORS INC | Series C |
| Baupost Group | Post Ipo Equity |
Orexigen Therapeutics's top competitor, Gilead Sciences, earned an annual revenue of $28.8B.
Orexigen Therapeutics's smallest competitor is Intellia Therapeutics with revenue of $57.9M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Med Immune Inc | $56,355 | $1.7B | 5,000 | - |
| SIGA Technologies | $71,494 | $115.5M | 43 | 1 |
| Ligand Pharmaceuticals | $82,001 | $241.5M | 116 | - |
| Amneal Pharmaceuticals | $76,227 | $2.8B | 6,500 | 100 |
| Corcept Therapeutics | $99,172 | $675.0M | 238 | 59 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 652 |
| Sagent Pharmaceuticals | $102,033 | $318.3M | 440 | 6 |
| Neurocrine Biosciences | $78,232 | $2.4B | 400 | 369 |
| Intellia Therapeutics | $79,975 | $57.9M | 211 | 12 |
Zippia gives an in-depth look into the details of Orexigen Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Orexigen Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Orexigen Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Orexigen Therapeutics. The data presented on this page does not represent the view of Orexigen Therapeutics and its employees or that of Zippia.
Orexigen Therapeutics may also be known as or be related to Orexigen Therapeutics, Orexigen Therapeutics Inc, Orexigen Therapeutics Inc. and Orexigen Therapeutics, Inc.